161 related articles for article (PubMed ID: 14563633)
1. Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells.
Zhang W; Chuang YJ; Swanson R; Li J; Seo K; Leung L; Lau LF; Olson ST
Blood; 2004 Feb; 103(4):1185-91. PubMed ID: 14563633
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains.
Zhang W; Swanson R; Xiong Y; Richard B; Olson ST
J Biol Chem; 2006 Dec; 281(49):37302-10. PubMed ID: 17040907
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic antithrombin induces global changes in the gene expression profile of endothelial cells.
Zhang W; Chuang YJ; Jin T; Swanson R; Xiong Y; Leung L; Olson ST
Cancer Res; 2006 May; 66(10):5047-55. PubMed ID: 16707426
[TBL] [Abstract][Full Text] [Related]
4. The heparin-binding site of antithrombin is crucial for antiangiogenic activity.
Zhang W; Swanson R; Izaguirre G; Xiong Y; Lau LF; Olson ST
Blood; 2005 Sep; 106(5):1621-8. PubMed ID: 15905187
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
[TBL] [Abstract][Full Text] [Related]
6. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.
Whitelock JM; Murdoch AD; Iozzo RV; Underwood PA
J Biol Chem; 1996 Apr; 271(17):10079-86. PubMed ID: 8626565
[TBL] [Abstract][Full Text] [Related]
7. Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells.
Dodge GR; Boesler EW; Jimenez SA
Lab Invest; 1995 Nov; 73(5):649-57. PubMed ID: 7474938
[TBL] [Abstract][Full Text] [Related]
8. Internalization of basic fibroblast growth factor at the mouse blood-brain barrier involves perlecan, a heparan sulfate proteoglycan.
Deguchi Y; Okutsu H; Okura T; Yamada S; Kimura R; Yuge T; Furukawa A; Morimoto K; Tachikawa M; Ohtsuki S; Hosoya K; Terasaki T
J Neurochem; 2002 Oct; 83(2):381-9. PubMed ID: 12423248
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells.
Larsson H; Sjöblom T; Dixelius J; Ostman A; Ylinenjärvi K; Björk I; Claesson-Welsh L
Cancer Res; 2000 Dec; 60(23):6723-9. PubMed ID: 11118058
[TBL] [Abstract][Full Text] [Related]
10. Lead inhibits the core protein synthesis of a large heparan sulfate proteoglycan perlecan by proliferating vascular endothelial cells in culture.
Fujiwara Y; Kaji T
Toxicology; 1999 Apr; 133(2-3):159-69. PubMed ID: 10378482
[TBL] [Abstract][Full Text] [Related]
11. Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA.
Aviezer D; Iozzo RV; Noonan DM; Yayon A
Mol Cell Biol; 1997 Apr; 17(4):1938-46. PubMed ID: 9121441
[TBL] [Abstract][Full Text] [Related]
12. Endothelial proteoglycans inhibit bFGF binding and mitogenesis.
Forsten KE; Courant NA; Nugent MA
J Cell Physiol; 1997 Aug; 172(2):209-20. PubMed ID: 9258342
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity.
Pillarisetti S
Trends Cardiovasc Med; 2000 Feb; 10(2):60-5. PubMed ID: 11150731
[TBL] [Abstract][Full Text] [Related]
14. Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth.
Furumatsu T; Nishida K; Kawai A; Namba M; Inoue H; Ninomiya Y
Int J Cancer; 2002 Jan; 97(3):313-22. PubMed ID: 11774282
[TBL] [Abstract][Full Text] [Related]
15. p27 Nuclear localization and growth arrest caused by perlecan knockdown in human endothelial cells.
Sakai K; Oka K; Matsumoto K; Nakamura T
Biochem Biophys Res Commun; 2010 Feb; 392(3):403-8. PubMed ID: 20074558
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of perlecan expression contributes to the inhibition of rat cardiac microvascular endothelial cell proliferation induced by hypoxia.
Li YZ; Liu XH; Cai LR
Sheng Li Xue Bao; 2007 Apr; 59(2):221-6. PubMed ID: 17437047
[TBL] [Abstract][Full Text] [Related]
17. Effect of transforming growth factor-beta 1 and basic fibroblast growth factor on the expression of cell surface proteoglycans in human lung fibroblasts. Enhanced glycanation and fibronectin-binding of CD44 proteoglycan, and down-regulation of glypican.
Romarís M; Bassols A; David G
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):73-81. PubMed ID: 7544118
[TBL] [Abstract][Full Text] [Related]
18. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis.
Aviezer D; Hecht D; Safran M; Eisinger M; David G; Yayon A
Cell; 1994 Dec; 79(6):1005-13. PubMed ID: 7528102
[TBL] [Abstract][Full Text] [Related]
19. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
[TBL] [Abstract][Full Text] [Related]
20. Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes.
Kaneider NC; Reinisch CM; Dunzendorfer S; Römisch J; Wiedermann CJ
J Cell Sci; 2002 Jan; 115(Pt 1):227-36. PubMed ID: 11801740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
